Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Libai Lu
ResearcherPublications, citations & collaboration network
Libai Lu is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 20 works, 282 citations, an h-index of 9 and an i10-index of 9.
20
Works
282
Citations
9
h-index
9
i10-index
IDs:OpenAlex
How has Libai Lu's publication output changed over time?
ScholarIQpublication output · 2019–2025
Output declined50% over the shown period — from 2 works in 2019 to 1 in 2025.
2
3
3
2
1
20192020202120242025
What are the most-cited papers on Libai Lu?
ScholarIQmost cited works
miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway
Jianchu Wang, Libai Lu, Zongjiang Luo, Wenchuan Li, Yuan Lu, Qianli Tang, Jian Pu
Biomedicine & Pharmacotherapy. 201969 CitationsOPEN ACCESS
Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression
Jianchu Wang, Wei Wang, Qianli Tang, Libai Lu, Zongjiang Luo, Wenchuan Li, Yuan Lu, Jian Pu
Cancer Medicine. 202043 CitationsOPEN ACCESS
CircCAMSAP1 promotes hepatocellular carcinoma progression through miR‐1294/GRAMD1A pathway
Zongjiang Luo, Libai Lu, Qianli Tang, Wei Wang, Pengyu Chen, Yi‐Chen Chen, Jian Pu, Jianchu Wang
S76698325. 202143 CitationsOPEN ACCESS
LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4
Jianchu Wang, Qianli Tang, Libai Lu, Zongjiang Luo, Wenchuan Li, Yuan Lu, Jian Pu
S65405509. 202025 Citations
Insight into the molecular mechanism of LINC00152/miR‐215/CDK13 axis in hepatocellular carcinoma progression
Jianchu Wang, Ying Zhang, Libai Lu, Yuan Lu, Qianli Tang, Jian Pu
Journal of Cellular Biochemistry. 201923 CitationsOPEN ACCESS
Related on ScholarIQ
Institute for Conflict Research
Institution
miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway
Paper
Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression
Paper
CircCAMSAP1 promotes hepatocellular carcinoma progression through miR‐1294/GRAMD1A pathway
Paper
LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4
Paper
Insight into the molecular mechanism of LINC00152/miR‐215/CDK13 axis in hepatocellular carcinoma progression
Paper